Abstract
Iron chelating drugs can impede the rapid reproduction of tumor cells. Among these drugs, deferasirox (DEF) have shown antitumor properties and therefore been selected for this study. The aim of this study was preparation and characterization of the bifunctional polymeric nanoparticles (NPs) by targeting moieties which is applied in cancer.
Therefore, DEF NPs were fabricated by exploiting of PLGA-PEG-FOL conjugate and combination of sonication and emulsification/solvent evaporation technique. Then the influence of important factors including the amount of vitamin E TPGS as a safe surfactant and the ratio of drug to polymer in organic phase was evaluated. Some formulations showed suitable size distribution below 200 nm with high drug entrapment. Drug release study indicated sustained release profile of DEF encapsulated in NPs. Stability study showed acceptable condition for preserving the formulation during six months.
Keywords: Bifunction, deferasirox, drug delivery, nanotechnology, PLGA-PEG-folate.
Nanoscience & Nanotechnology-Asia
Title:Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Volume: 4 Issue: 2
Author(s): Mina Mir and Pedram Ebrahimnejad
Affiliation:
Keywords: Bifunction, deferasirox, drug delivery, nanotechnology, PLGA-PEG-folate.
Abstract: Iron chelating drugs can impede the rapid reproduction of tumor cells. Among these drugs, deferasirox (DEF) have shown antitumor properties and therefore been selected for this study. The aim of this study was preparation and characterization of the bifunctional polymeric nanoparticles (NPs) by targeting moieties which is applied in cancer.
Therefore, DEF NPs were fabricated by exploiting of PLGA-PEG-FOL conjugate and combination of sonication and emulsification/solvent evaporation technique. Then the influence of important factors including the amount of vitamin E TPGS as a safe surfactant and the ratio of drug to polymer in organic phase was evaluated. Some formulations showed suitable size distribution below 200 nm with high drug entrapment. Drug release study indicated sustained release profile of DEF encapsulated in NPs. Stability study showed acceptable condition for preserving the formulation during six months.
Export Options
About this article
Cite this article as:
Mir Mina and Ebrahimnejad Pedram, Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox, Nanoscience & Nanotechnology-Asia 2014; 4 (2) . https://dx.doi.org/10.2174/2210681205666150515000224
DOI https://dx.doi.org/10.2174/2210681205666150515000224 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |
Call for Papers in Thematic Issues
Nanotechnology for Energy Harness and Material Development
The energy industry is one of the many that is being revolutionized by nanotechnology. There is great hope for the commercialization of these breakthroughs since they have the potential to make energy production safer, far more sustainable, greater efficient, and less expensive. Nanotechnology is being studied for its potential to ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Immune System of Cancer Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Latest Results for Anti-Angiogenic Drugs in Cancer Treatment
Current Pharmaceutical Design Chemoprevention of Breast Cancer by Dietary Compounds
Anti-Cancer Agents in Medicinal Chemistry Improving Cancer Therapeutics by Molecular Profiling
Current Drug Metabolism MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
Current Medicinal Chemistry The Pharmacological Treatment of Cachexia
Current Drug Targets MicroRNAs in Human Virus Genomes: Helping Hands for Viral Infection
MicroRNA Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Opposing – Activating or Inhibitory – Effects of Cimetidine and Daidzein on Human ADH1C Activity Depending on Substrates and Solvents
Drug Metabolism Letters The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function
Current Chemical Biology Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism Review of Childhood Obesity (Balar Athidhoola Rogam) in Traditional Siddha Indian Medicine
Current Traditional Medicine Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies
Current Topics in Medicinal Chemistry Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma
Current Topics in Medicinal Chemistry Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Anti-Cancer Agents in Medicinal Chemistry TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension
Current Topics in Medicinal Chemistry De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer
Current Cancer Drug Targets